JPWO2021183370A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021183370A5
JPWO2021183370A5 JP2022554529A JP2022554529A JPWO2021183370A5 JP WO2021183370 A5 JPWO2021183370 A5 JP WO2021183370A5 JP 2022554529 A JP2022554529 A JP 2022554529A JP 2022554529 A JP2022554529 A JP 2022554529A JP WO2021183370 A5 JPWO2021183370 A5 JP WO2021183370A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
heteroaryl
halo
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022554529A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516494A5 (https=
JP2023516494A (ja
JP7796032B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/020992 external-priority patent/WO2021183370A1/en
Publication of JP2023516494A publication Critical patent/JP2023516494A/ja
Publication of JP2023516494A5 publication Critical patent/JP2023516494A5/ja
Publication of JPWO2021183370A5 publication Critical patent/JPWO2021183370A5/ja
Priority to JP2025272737A priority Critical patent/JP2026040565A/ja
Application granted granted Critical
Publication of JP7796032B2 publication Critical patent/JP7796032B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022554529A 2020-03-11 2021-03-05 免疫調節活性を持つ化合物およびその治療的使用 Active JP7796032B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025272737A JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062987914P 2020-03-11 2020-03-11
US62/987,914 2020-03-11
PCT/US2021/020992 WO2021183370A1 (en) 2020-03-11 2021-03-05 Compounds with immunomodulatory activity and therapeutic uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025272737A Division JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Publications (4)

Publication Number Publication Date
JP2023516494A JP2023516494A (ja) 2023-04-19
JP2023516494A5 JP2023516494A5 (https=) 2024-03-12
JPWO2021183370A5 true JPWO2021183370A5 (https=) 2024-03-12
JP7796032B2 JP7796032B2 (ja) 2026-01-08

Family

ID=77671929

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022554529A Active JP7796032B2 (ja) 2020-03-11 2021-03-05 免疫調節活性を持つ化合物およびその治療的使用
JP2025272737A Pending JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025272737A Pending JP2026040565A (ja) 2020-03-11 2025-12-22 免疫調節活性を持つ化合物およびその治療的使用

Country Status (7)

Country Link
US (1) US12448359B2 (https=)
EP (1) EP4117647A4 (https=)
JP (2) JP7796032B2 (https=)
CN (1) CN115551497B (https=)
CA (1) CA3175848A1 (https=)
MX (1) MX2022011171A (https=)
WO (1) WO2021183370A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021183370A1 (en) 2020-03-11 2021-09-16 Purdue Research Foundation Compounds with immunomodulatory activity and therapeutic uses thereof
US12159227B2 (en) * 2020-03-13 2024-12-03 Korea University Research And Business Foundation System for predicting optical properties of molecules based on machine learning and method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2787844C (en) 2010-02-03 2019-08-27 Biomarin Pharmaceutical Inc. Dihydropyridophthalazinone inhibitors of poly(adp-ribose) polymerase (parp) for use in treatment of diseases associated with a pten deficiency
JP6417419B2 (ja) 2013-09-04 2018-11-07 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 免疫調節剤として有用な化合物
US9850225B2 (en) * 2014-04-14 2017-12-26 Bristol-Myers Squibb Company Compounds useful as immunomodulators
EP3190103A1 (en) 2016-01-08 2017-07-12 Rijksuniversiteit Groningen Inhibitors of the pd-1/pd-l1 protein/protein interaction
TWI727010B (zh) 2016-03-10 2021-05-11 日商新日本理化股份有限公司 粉狀1, 4-環己二羧酸
JP7423598B2 (ja) * 2018-04-12 2024-01-29 メドイミューン・リミテッド がんの治療で使用するためのｌｉｆ阻害剤とｐｄ－１軸阻害剤との組み合わせ
WO2021183370A1 (en) 2020-03-11 2021-09-16 Purdue Research Foundation Compounds with immunomodulatory activity and therapeutic uses thereof

Similar Documents

Publication Publication Date Title
RU2403258C2 (ru) Тиазолилдигидроиндазолы
RU2324684C2 (ru) Пиримидиновые производные
RU2011142154A (ru) Производные фосфлокуназола, их синтез и применение в препаратах длительного действия
JP2024001048A5 (https=)
EA011099B1 (ru) Терапевтические соединения
JPS5995269A (ja) 抗てんかん性医薬品
AU2018251118A1 (en) Pharmaceutical composition containing MOR agonist and KOR agonist, and uses thereof
JP2017512183A5 (https=)
JP2021505547A (ja) 疼痛を治療するための薬物の製造におけるｍｏｒアゴニストと組み合わせたｋｏｒアゴニストの使用
JP2023081922A (ja) 腎臓損傷の治療及び予防
EP2139889B1 (en) Amino-naphthyridine derivatives
WO2014108407A1 (en) Pyridone derivatives and their use in the treatment, amelioration or prevention of a viral disease
CZ140696A3 (en) Hiv protease inhibitor precursors and pharmaceutical compositions containing thereof
RU2008136762A (ru) Циклические сульфоны как ингибиторы васе
EP2139463B1 (en) Anti-infective agents
RU2007125130A (ru) Применение атазанавира для улучшения фармакокинетики лекарственных средств, метаболизируемых ugt1a1
JPWO2021183370A5 (https=)
CN101365461B (zh) 舒林酸衍生物、其用途和其制备
JP2009519946A (ja) タンパク質と結合パートナーとの相互作用を阻害するための化合物及び方法
RU2008129623A (ru) Ингибиторы ccr9 активности
RU2019123982A (ru) Комбинация mcl-1 ингибитора и таксанового соединения, их применения и фармацевтические композиции
EA018566B1 (ru) Фармацевтические комбинации 5-фторурацила и производных 1,4-дигидропиридина и их применение для лечения рака
JP2010526073A (ja) 癌または前癌性症状およびその他の症状の治療のためのジヒドロピリジン誘導体
WO2020221894A1 (en) Antiviral compounds
IE904076A1 (en) Treatment of multi-drug resistant tumors with¹pyridyloxazole-2-ones